Evidence map›Paper›PMID 40145071›Full record

ArticleGHM open2021

Burden of cancer attributable to tobacco smoke in Japan in 2015.

Kota Katanoda, Mayo Hirabayashi, Eiko Saito, Megumi Hori, Sarah Krull Abe, Tomohiro Matsuda, Manami Inoue The Cancer Paf Japan Collaborators

Abstract read
In one paragraph

Article in GHM open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. The spectrum of TP53 mutations in Rwandan patients with gastric cancer.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kota KatanodaDivision of Cancer Statistics Integration, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.
Mayo HirabayashiDivision of Prevention, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Eiko SaitoDivision of Cancer Statistics Integration, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.
Megumi HoriDivision of Cancer Statistics Integration, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.
Sarah Krull AbeDivision of Prevention, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Tomohiro MatsudaNational Cancer Registry Section, Center for Cancer Registries, Center for Cancer Control and Information Services/Office of International Affairs, Strategic Planning Bureau National Cancer Center, National Cancer Center, Tokyo, Japan.
Manami Inoue The Cancer Paf Japan CollaboratorsDivision of Prevention, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tobacco is the greatest single cause of many non-communicable diseases, including cancer. We calculated the proportion of cancer incidence and mortality in 2015 attributable to tobacco smoking and exposure to secondhand smoke (SHS). Data on the prevalence of active smoking were derived from the 2005 Japanese National Health and Nutrition Survey by age group and gender. For SHS exposure prevalence, data from a nationwide cross-sectional survey from 2004-2005 were used. Based on standard formulas, population attributable fractions (PAFs) for each cancer causally associated with active smoking, namely the oral cavity and pharynx, esophagus, stomach, colon, rectum, liver, pancreas, nasal, larynx, lung, uterine cervix, kidney, renal pelvis and ureter, bladder, and acute myeloid leukemia, were calculated for each sex and age group and aggregated to obtain the PAF among total cancer incidence and mortality. For SHS exposure, PAFs for lung cancer and total cancer were calculated using the same method. For Japan in 2015, 145,765 new cancer cases and 72,520 cancer deaths, corresponding to a PAF of 15.2% for total cancer incidence and 19.6% for total cancer mortality, were attributable to active tobacco smoking. For SHS exposure, 0.5% of total cancer incidence and 0.7% of total cancer mortality in 2015 were attributable. Tobacco is still one of the major causes of cancer in Japan.

Indexed as

cancerJapanpopulation attributable fractionsecondhand smoketobacco smoke

Identifiers

PMID40145071
PMCPMC11933966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.